EMILY LUTZ: Open Payments
NPI 1902450117 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,456 in 80 payments from 14 companies in 2025. Trend: 2023 $2,513 · 2024 $2,573 · 2025 $2,456
Food & beverage: $2,308Education: $148
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $1,112 |
| Janssen Biotech, Inc. | 11 | $431 |
| ABBVIE INC. | 15 | $228 |
| Amgen Inc. | 3 | $163 |
| E.R. Squibb & Sons, L.L.C. | 2 | $111 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $89 |
| Galderma Laboratories, L.P. | 4 | $62 |
| UCB, Inc. | 2 | $56 |
| Lilly USA, LLC | 3 | $55 |
| PFIZER INC. | 3 | $53 |
Products named: TREMFYA, Rhapsido, SKYRIZI, OTEZLA, COSENTYX, Sotyktu, Bimzelx, CIBINQO.
Industry payments across IN — which companies pay providers there.
